HTA9 A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy
作者
R. Schwarz,Ágnes Benedict,P. Rakonczai,Balázs Dobi,Necdet B. Gunsoy,Virginie Lavaud
出处
期刊:Value in Health [Elsevier] 日期:2025-12-01卷期号:28 (12): S401-S401